approval
saveWINREVAIR (SOTATERCEPT-CSRK) — FDA approval
community read0 votes
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
- recallMerck Sharp & Dohme LLC recall (Cls II)Dec 31, 2025
- recallMerck Sharp & Dohme LLC recall (Cls II)Dec 31, 2025
- approvalsotatercept: WINREVAIR (SOTATERCEPT-CSRK) — FDA approvalOct 24, 2025
- approvalPOSACONAZOLE: NOXAFIL (POSACONAZOLE) — FDA approvalJan 27, 2026
comments(0)
5-min edit window · permanent after that